Fate Therapeutics, Inc. (FATE)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Fate Therapeutics, Inc. (FATE) is listed on Nasdaq, where it has traded since October 1, 2013.
- Listed On
- Nasdaq
- Listed Since
- October 1, 2013
- Employees
- 161
- Market Cap
- $282M
About Fate Therapeutics, Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 149 institutions reported holding FATE, with 71.5 million shares worth $193.1 million in aggregate. The largest reported holder was Redmile Group, with 12.9 million shares worth $34.8 million. Of the 5 largest holders listed below, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Redmile Group | 12,872,946 | $35M | Unchanged |
| Vanguard | 9,773,984 | $26M | Added 7.87% |
| BlackRock | 7,298,895 | $20M | Reduced 27.51% |
| Acadian Asset Management | 4,351,250 | $12M | Added 5.61% |
| AQR Capital Management | 3,837,229 | $10M | Added 27.84% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is FATE?
Fate Therapeutics, Inc. (FATE) is listed on Nasdaq, where it has traded since October 1, 2013.
Who are the largest institutional holders of FATE?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of FATE were Redmile Group, Vanguard and BlackRock.
How many institutions own FATE?
149 institutions reported a position in FATE for the quarter ended June 30, 2026, worth $193.1 million in total.
Did institutions buy or sell FATE last quarter?
Of the 5 largest reported holders, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for FATE.
Every reported institutional holder, plus insider and congressional trades in FATE, on SentiSense.